Guenther L, Potts Bleakman A, Weisman J, Poulin Y, Spelman L, Burge R, et al. Ixekizumab Results in Persistent Clinical Improvement in Moderate-to-Severe Genital Psoriasis During a 52 Week, Randomized, Placebo-Controlled, Phase 3 Clinical Trial. Acta Derm Venereol [Internet]. 2020 Jan. 7 [cited 2024 Nov. 28];100(1):1-9. Available from: https://medicaljournalssweden.se/actadv/article/view/1629